Source: International Congress 2016 – New signalling pathways in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jeffrey T.-J. Huang (Dundee, United Kingdom), Jeffrey T.-J. Huang, Charlotte E. Bolton, Bruce E. Miller, Ruth M. Tal-Singer, Roberto Robinovich, Colin Palmer, Neil Thomson, William Macnee. Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease. Eur Respir J 2016; 48: Suppl. 60, 4011

Member's Comments

No comment yet.

Related content which might interest you: Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Systemic inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Characterization of elastin degradation biomarkers in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Systemic vascular function in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Age-dependent elastin degradation is enhanced in chronic obstructive pulmonary disease Source: Eur Respir J 2016; 48: 1215-1218 Year: 2016 Increased serum level of apelin in chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Local and systemic inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease Source: International Congress 2014 – Markers Year: 2014 Biomarkers in the management of COPD Source: Eur Respir Rev 2009; 18: 96-104 Year: 2009 Systemic effects of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=224 Year: 2006 Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Inflammation in COPD: a link to systemic comorbidities Source: Eur Respir Rev 2007; 16: 91-97 Year: 2007 Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Effect of statins on endothelial dysfunction in patients with chronic obstructive pulmonary disease and metabolic syndrome Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Mechanisms of ECG changes in chronic obstructive pulmonary disease Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease Source: Eur Respir J 2004; 23: 629-636 Year: 2004 Systemic manifestations in smokers and mild/moderate chronic obstructive pulmonary disease Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD: points to ponder Year: 2014